CAS 154874-94-9: N-BOC-4-CHLORO-PIPERIDINE
Formula:C10H18ClNO2
InChI:InChI=1/C10H18ClNO2/c1-10(2,3)14-9(13)12-6-4-8(11)5-7-12/h8H,4-7H2,1-3H3
- Synonyms:
- 1-Boc-4-Chloro-Piperidine
- Tert-Butyl 4-Chloropiperidine-1-Carboxylate
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 1-BOC-4-chloropiperidine, 97% REF: AC-43501CAS: 154874-94-9 | 97% | To inquire | Wed 26 Feb 25 |
 | 1-Boc-4-chloro-piperidine REF: 10-F037053CAS: 154874-94-9 | 97.0% | 20.00 €~109.00 € | Wed 05 Mar 25 |
 | N-BOC-4-Chloropiperidine REF: 54-OR909607CAS: 154874-94-9 | 97+% | 75.00 €~276.00 € | Tue 11 Mar 25 |
 | N-Boc-4-Chloro-piperidine REF: 3D-FB51775CAS: 154874-94-9 | Min. 95% | - - - | Discontinued product |
1-BOC-4-chloropiperidine, 97%
CAS:154874-94-9
This Thermo Scientific Chemicals brand product was originally part of the Acros Organics product portfolio. …
Purity:
97%
Color and Shape:
Colorless to white, Liquid or low melting solid
Ref: AC-43501
| 1g | To inquire | ||
| 5g | To inquire |
Estimated delivery in United States, on Wednesday 26 Feb 2025
1-Boc-4-chloro-piperidine
CAS:154874-94-9
Purity:
97.0%
Color and Shape:
Liquid
Molecular weight:
219.7100067138672
Ref: 10-F037053
| 1g | 20.00 € | ||
| 5g | 25.00 € | ||
| 10g | 49.00 € | ||
| 25g | 109.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025
N-BOC-4-Chloropiperidine
CAS:154874-94-9
Formula:
C10H18ClNO2
Purity:
97+%
Color and Shape:
white solid
Molecular weight:
219.71g/mol
Ref: 54-OR909607
| 5g | 75.00 € | ||
| 25g | 276.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
N-Boc-4-Chloro-piperidine
CAS:154874-94-9
N-Boc-4-Chloro-piperidine is a molecule that has shown to modulate the toll-like receptor, which is involved …
Formula:
C10H18ClNO2
Purity:
Min. 95%
Molecular weight:
219.71 g/mol
Ref: 3D-FB51775
| 1g | Discontinued | Request information | |
| 2g | Discontinued | Request information | |
| 5g | Discontinued | Request information | |
| 250mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
